Skip to main content
. Author manuscript; available in PMC: 2013 Oct 30.
Published in final edited form as: Am J Hypertens. 2011 Feb 10;24(5):10.1038/ajh.2011.12. doi: 10.1038/ajh.2011.12

Table 1.

Baseline Subject Characteristics

Variable Placebo 2000 IU p-value
N 23 22 -
Men (%) 52 41 0.65
Age (yrs) 31±2 29±2 0.19
Height (cm) 1.72±0.02 1.70±0.02 0.65
Weight (kg) 85.5±4.3 87.2±5.2 0.54
BMI (m2/kg) 29.1±1.5 30.4±1.8 0.35
Body fat (%) 29.8±2.7 31.1±2.5 0.48
SBP (mm Hg) 123±3 124±4 0.19
DBP (mm Hg) 75±2 74±2 0.60
TC (mg/dL) 154+8 136±6 <0.01
HDL (mg/dL) 49±3 52±3 0.97
LDL (mg/dL) 101±8 71±7 0.18
TG (mg/dL) 81±5 67±4 0.13
HbA1c (mg/dL) 5.4±0.1 5.6±0.2 0.22
25(OH)D (nmol/L) 38.2±3.0 34.3±2.2 0.40
PTH (pg/ml) 24.8±2.8 21.0±2.6 0.31
Ca (mg/dL) / Cr (mg/dL) 0.10±0.07 0.12±0.08 0.70

Values are mean±sem. Abbreviations: BMI, Body mass index; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; TC, Total cholesterol; HDL, High density lipo-protein; LDL, Low density lipo-protein; TG, Triglycerides; HbA1c, Hemoglobin A1c; 25(OH)D, 25-hydroxyvitamin D; PTH, Serum parathyroid hormone; Ca/Cr, Urine calcium: creatinine.